Diethylstilbestrol (DES): Understanding the Risks and History

Diethylstilbestrol (DES) – A Historical Tragedy

DES is a synthetic estrogen prescribed 1940s–1971 to prevent miscarriage. In 1971, FDA withdrew it after linking prenatal exposure to:

  • Clear cell adenocarcinoma of vagina/cervix in "DES daughters" (rare but devastating).
  • Reproductive tract anomalies (T‑shaped uterus, infertility).
  • Increased breast cancer risk in mothers who took it.

DES is no longer used in pregnancy. Exposed individuals should inform providers for appropriate screening (e.g., annual vaginal/cervical exams for daughters).

Medical Billing - Related Articles